Amylin and amylin agonists for treating schizophrenia

Disclosed is the use of an amylin peptide or an amylin agonist peptide comprising the amino acid sequence of any one of SEQ ID NOs: 1-31, 33, 35-67, 80-83, and 86-253 for the preparation of a medicament for the treatment of schizophrenia. (62) Divided Out of 561936

Saved in:
Bibliographic Details
Main Authors YOUNG, ANDREW A, HANLEY, MICHAEL, MACK, CHRISTINE M, LAUGERO, KEVIN D, PARKES, DAVID G
Format Patent
LanguageEnglish
Published 26.03.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is the use of an amylin peptide or an amylin agonist peptide comprising the amino acid sequence of any one of SEQ ID NOs: 1-31, 33, 35-67, 80-83, and 86-253 for the preparation of a medicament for the treatment of schizophrenia. (62) Divided Out of 561936
Bibliography:Application Number: NZ20060578299